| Annual Report to shareholders | Oct 22, 2026 | Annual report | ASX |
|---|
| Notice of Annual General Meeting/Proxy Form | Oct 22, 2026 | Meeting notice | ASX |
|---|
| Notification of cessation of securities - BMT | Oct 20, 2026 | Financing | ASX |
|---|
| Notification of cessation of securities - BMT | Oct 6, 2026 | Financing | ASX |
|---|
| Change of Director's Interest Notice - M Hill | Sep 3, 2026 | Ownership change notice | ASX |
|---|
| Change of Director's Interest Notice - M Bowles | Aug 31, 2026 | Ownership change notice | ASX |
|---|
| Cleansing Notice | Aug 27, 2026 | Financing | ASX |
|---|
| Application for quotation of securities - BMT | Aug 27, 2026 | Financing | ASX |
|---|
| FY26 Annual Results Investor Presentation | Aug 27, 2026 | Other filings | ASX |
|---|
| Appendix 4G and Corporate Governance Statement | Aug 27, 2026 | Other filings | ASX |
|---|
| FY26 Full-Year Investor Update | Aug 27, 2026 | Results | ASX |
|---|
| Appendix 4E and FY26 Annual Report | Aug 27, 2026 | Annual report | ASX |
|---|
| Notification of cessation of securities - BMT | Aug 13, 2026 | Notification letter | ASX |
|---|
| Cleansing Notice | Aug 10, 2026 | Financing | ASX |
|---|
| Application for quotation of securities - BMT | Aug 10, 2026 | Financing | ASX |
|---|
| Cleansing Notice | Aug 3, 2026 | Financing | ASX |
|---|
| Application for quotation of securities - BMT | Aug 3, 2026 | Financing | ASX |
|---|
| Proposed issue of securities - BMT | Jul 31, 2026 | Financing | ASX |
|---|
| Variation to CEO's Employment Agreement | Jul 31, 2026 | Management or board change | ASX |
|---|
| Beamtree appoints Gareth Pye as Chief Executive Officer | Jun 14, 2026 | Management or board change | ASX |
|---|
| $2m Saudi contract win & Strategic Review Interim Update | May 4, 2026 | Operations update | ASX |
|---|
| 1H FY26 Results - Investor Presentation | Feb 18, 2026 | Results | ASX |
|---|
| BMT FY26 Half-Year Investor Update | Feb 18, 2026 | Interim report | ASX |
|---|
| Appendix 4D and FY26 Interim Report | Feb 18, 2026 | Interim report | ASX |
|---|
| Q1 FY26 Trading Update, Continued Momentum | Oct 14, 2025 | Quarterly report | ASX |
|---|
| FY25 Results Investor Presentation | Aug 27, 2025 | Results | ASX |
|---|
| FY25 Results Announcement | Aug 27, 2025 | Results | ASX |
|---|
| Preliminary Final Report | Aug 27, 2025 | Annual report | ASX |
|---|
| Beamtree Signs $1m Singapore Coding Audit Contract | Aug 27, 2025 | Operations update | ASX |
|---|
| Strategic Partnership with NHS Confederation | May 30, 2025 | Acquisition or disposal | ASX |
|---|
| Q3 FY25 Trading Update | May 5, 2025 | Quarterly report | ASX |
|---|
| Strategic contract wins for Autonomous coding- Clarification | Mar 24, 2025 | Operations update | ASX |
|---|
| Pause in Trading | Mar 23, 2025 | Trading halt or suspension | ASX |
|---|
| Strategic contract wins for Autonomous coding | Mar 23, 2025 | Operations update | ASX |
|---|
| $4m contract win to deliver PICQ for the Republic of Ireland | Mar 20, 2025 | Material contract | ASX |
|---|
| 1H FY25 Results - Investor Presentation | Feb 18, 2025 | Interim report | ASX |
|---|
| 1H FY25 Results and Trading Update | Feb 18, 2025 | Results | ASX |
|---|
| Appendix 4D and FY25 Interim Report | Feb 18, 2025 | Interim report | ASX |
|---|
| Beamtree appoints new CEO | Feb 3, 2025 | Management or board change | ASX |
|---|
| Q1 FY25 Trading Update | Nov 3, 2024 | Quarterly report | ASX |
|---|
| Tim Kelsey to step down as Beamtree CEO in March 2025 | Oct 14, 2024 | Management or board change | ASX |
|---|
| Major recurring revenue contract win in Saudi Arabia | Sep 24, 2024 | Operations update | ASX |
|---|
| FY24 Results Investor Presentation | Aug 26, 2024 | Other filings | ASX |
|---|
| FY24 Results Announcement | Aug 26, 2024 | Other filings | ASX |
|---|
| FY24 Unaudited Annual Results - Investor Presentation | Aug 5, 2024 | Other filings | ASX |
|---|
| Unaudited FY24 results, strong cashflow & good FY25 outlook | Aug 5, 2024 | Guidance | ASX |
|---|
| Beamtree wins AU$3.6m contract in Saudi Arabia | May 27, 2024 | Other filings | ASX |
|---|
| Q3 FY24 Trading Update | Apr 30, 2024 | Quarterly report | ASX |
|---|
| 1H FY24 Investor Presentation | Feb 13, 2024 | Results | ASX |
|---|
| 1H FY24 Results and Trading Update | Feb 13, 2024 | Results | ASX |
|---|
| Appendix 4D and FY24 Interim Report | Feb 13, 2024 | Interim report | ASX |
|---|
| Annual General Meeting Addresses and Presentation | Nov 20, 2023 | Meeting outcome | ASX |
|---|
| Q1 FY24 Trading Update | Oct 26, 2023 | Quarterly report | ASX |
|---|
| FY23 Results Announcement | Aug 23, 2023 | Other filings | ASX |
|---|
| FY23 Investor Presentation | Aug 23, 2023 | Other filings | ASX |
|---|
| Q4 FY23 Trading Update | Jul 26, 2023 | Other filings | ASX |
|---|
| Beamtree secures first contract in Canada | Jun 8, 2023 | Other filings | ASX |
|---|
| Beamtree completes $5m capital raise | May 29, 2023 | Other filings | ASX |
|---|
| Trading Halt | May 25, 2023 | Trading halt or suspension | ASX |
|---|
| Q3 FY23 Trading Update Presentation | Apr 27, 2023 | Other filings | ASX |
|---|
| Q3 FY23 Trading Update | Apr 26, 2023 | Other filings | ASX |
|---|
| Appendix 4D and FY23 Interim Report | Feb 14, 2023 | Interim report | ASX |
|---|
| 1H FY23 Investor Presentation | Feb 14, 2023 | Other filings | ASX |
|---|
| 1H FY23 Trading Highlights | Feb 14, 2023 | Other filings | ASX |
|---|
| BMT agrees revised contract terms Health Roundtable Limited | Jan 30, 2023 | Other filings | ASX |
|---|
| Clarification of contract with Abbott | Dec 16, 2022 | Other filings | ASX |
|---|
| Beamtree agrees new global contract with Abbott | Dec 15, 2022 | Other filings | ASX |
|---|
| Beamtree Trading Update | Oct 30, 2022 | Other filings | ASX |
|---|
| Beamtree announces partnership in Kingdom of Saudi Arabia | Oct 10, 2022 | Other filings | ASX |
|---|
| FY22 Results Announcement | Aug 23, 2022 | Other filings | ASX |
|---|
| FY22 Investor Presentation | Aug 23, 2022 | Other filings | ASX |
|---|
| BMT Business Update Presentation | May 17, 2022 | Operations update | ASX |
|---|
| BMT Business Update | May 17, 2022 | Operations update | ASX |
|---|
| BMT signs USD$7M 5-year contract for RippleDown Diagnostics | May 9, 2022 | Other filings | ASX |
|---|
| Beamtree confirms key renewal | Mar 30, 2022 | Other filings | ASX |
|---|
| BMT accelerates international growth - first NHS contracts | Mar 21, 2022 | Other filings | ASX |
|---|
| Half year results investor presentation | Feb 14, 2022 | Interim report | ASX |
|---|
| Beamtree 1H FY22 business update and financials | Feb 14, 2022 | Operations update | ASX |
|---|
| Appendix 4D and half year report | Feb 14, 2022 | Interim report | ASX |
|---|
| BMT and CALHN partner to pioneer AI for safer patient care | Sep 30, 2021 | Other filings | ASX |
|---|
| Beamtree acquisition presentation | Aug 30, 2021 | Acquisition or disposal | ASX |
|---|
| Proposed issue of securities - BMT | Aug 30, 2021 | Financing | ASX |
|---|
| Beamtree to acquire Potential(x) | Aug 30, 2021 | Acquisition or disposal | ASX |
|---|
| Investor Presentation Financial Year 2021 | Aug 26, 2021 | Other filings | ASX |
|---|
| Record FY21 results delivers sustainable growth | Aug 26, 2021 | Other filings | ASX |
|---|
| Successful renewal of key contracts and new contract wins | Jun 28, 2021 | Material contract | ASX |
|---|
| Appendix 4D and Interim Report | Feb 22, 2021 | Interim report | ASX |
|---|
| PKS receives $12 million in firm commitments to drive growth | Feb 22, 2021 | Other filings | ASX |
|---|
| PKS executes $2.5m renewal agreement with Philips | Jan 27, 2021 | Other filings | ASX |
|---|
| PKS agreement with ACT Pathology extended | Dec 22, 2020 | Other filings | ASX |
|---|
| Cleansing Notice and Potential Customer Contract Renewal | Dec 4, 2020 | Financing | ASX |
|---|
| PKS signs USD$1.65m agreement for national health data audit | Nov 18, 2020 | Other filings | ASX |
|---|
| PKS appoints internationally regarded CEO | Oct 5, 2020 | Other filings | ASX |
|---|
| PKS signs additional renewal agreement with Healthscope | Sep 17, 2020 | Other filings | ASX |
|---|
| PKS Investor Presentation Financial Year 2020 | Aug 28, 2020 | Other filings | ASX |
|---|
| PKS update for the financial year ending 30 June 2020 | Aug 28, 2020 | Other filings | ASX |
|---|
| 2020 Annual Report to shareholders and Appendix 4E | Aug 28, 2020 | Annual report | ASX |
|---|
| PKS signs new agreement with SA Pathology | Jul 12, 2020 | Other filings | ASX |
|---|
| PKS acquires Pavilion Health | Apr 20, 2020 | Acquisition or disposal | ASX |
|---|
| PKS signs renewal agreement with Healthscope NZ | Apr 17, 2020 | Other filings | ASX |
|---|
| Clarification on Renewal of Agreement | Apr 17, 2020 | Other filings | ASX |
|---|
| Half Yearly Report and Accounts | Feb 28, 2020 | Interim report | ASX |
|---|
| PKS executes Abbott License and Distribution Agreement | Nov 19, 2019 | Other filings | ASX |
|---|
| PKS update for quarter ending 30 September 2019 | Oct 29, 2019 | Other filings | ASX |
|---|
| FY19 Results Commentary | Aug 30, 2019 | Other filings | ASX |
|---|
| Appendix 4E | Aug 30, 2019 | Results | ASX |
|---|
| IPO Presentation | Jun 14, 2019 | Other filings | ASX |
|---|